September 19, 2017 3:58 PM ET

Company Overview of Sabin Vaccine Institute

Company Overview

National Headquarters

1889 F Street, N.W

Suite 200S

Washington, DC 20006-4400

United States

Founded in 2007

Key Executives for Sabin Vaccine Institute

Chief Executive Officer
President
Chief Operating Officer
President of Global Immunization
Communications Officer
Compensation as of Fiscal Year 2017.

Sabin Vaccine Institute Key Developments

Sabin Vaccine Institute Presents at BIO International Conference 2017, Jun-20-2017 10:45 AM

Sabin Vaccine Institute Presents at BIO International Conference 2017, Jun-20-2017 10:45 AM. Venue: San Diego Convention Center, San Diego, CA 2865, United States. Speakers: Amy Finan, Chief Executive Officer.

Sabin Vaccine Institute Appoints of Dr. Bruce Gellin as President, Global Immunization Effective March 1, 2017

Sabin Vaccine Institute announced the appointment of Dr. Bruce Gellin as President, Global Immunization. Dr. Gellin, a 15-year U.S. Department of Health and Human Services (HHS) veteran, has served as Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office since 2002. Among his roles, Dr. Gellin led discussions on behalf of the United States at high-level global and domestic policy advisory groups and was responsible for developing the National Vaccine Plan. In his new role, which will begin on March 1, 2017, Dr. Gellin will lead Sabin's global immunization efforts to champion sustainable, evidence-based solutions that prevent disease through vaccination and drive partnerships in the global health community. As an executive leader, he will also work with Finan, President Dr. Peter Hotez, Chief Operating Officer Brian Davis and the Sabin Board of Trustees to implement new organizational approaches to drive measurable outcomes.

Sabin Vaccine Institute Announces Management Changes

The Sabin Vaccine Institute announced the appointment of Amy Finan as its next chief executive officer. Finan, currently the senior vice president responsible for business development with the Biotechnology Innovation Organization, will assume her new role with Sabin on April 18, 2016. During her 11-year tenure with BIO, Finan played a critical role in expanding the organization's membership and revenue base and implementing forward-leaning approaches to fundraising, branding, marketing and programming. In 2011 and simultaneous with her BIO responsibilities, she also served as president of the s Biotechnology Institute, an organization founded by BIO in 1998 to promote life science education. Finan succeeds Michael W. Marine, who will retire on April 15, 2016.

Similar Private Companies By Industry

Company Name Region
Aryzta Us Holdings I Corp. United States
Michael Anthony Hernandez, A Professional Corp United States
!SOLUTIONS! Group United States
"Atlantic Tele-Satellite, Inc. United States
"D" Construction, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sabin Vaccine Institute, please visit www.sabin.org. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.